| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.653 | 25.806 | 28.521 | 22.858 | 38.274 | 35.149 | 38.788 | 35.572 | 47.845 | 82.604 |
| Total Income - EUR | 13.042 | 25.833 | 30.389 | 23.013 | 40.833 | 35.220 | 39.005 | 35.579 | 47.849 | 83.319 |
| Total Expenses - EUR | 10.415 | 14.145 | 17.188 | 19.782 | 21.477 | 19.548 | 28.568 | 22.056 | 43.235 | 55.631 |
| Gross Profit/Loss - EUR | 2.627 | 11.688 | 13.201 | 3.231 | 19.356 | 15.672 | 10.437 | 13.523 | 4.615 | 27.688 |
| Net Profit/Loss - EUR | 2.236 | 11.430 | 12.908 | 3.003 | 18.988 | 15.319 | 10.077 | 13.179 | 4.149 | 24.246 |
| Employees | 6 | 5 | 3 | 2 | 3 | 4 | 4 | 4 | 3 | 3 |
Check the financial reports for the company - Medicina Integrativa S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 627 | 1.786 | 731 | 1.680 | 1.477 | 1.316 | 1.147 | 977 |
| Current Assets | 2.671 | 13.835 | 26.965 | 32.933 | 45.827 | 62.787 | 55.371 | 70.612 | 68.261 | 66.576 |
| Inventories | 0 | 11 | 0 | 0 | 231 | 143 | 0 | 0 | 1.585 | 0 |
| Receivables | 1.753 | 3.977 | 6.626 | 18.372 | 34.385 | 42.946 | 46.519 | 36.524 | 33.593 | 48.581 |
| Cash | 918 | 9.847 | 20.338 | 14.561 | 11.211 | 19.698 | 8.853 | 34.088 | 33.083 | 17.992 |
| Shareholders Funds | 2.281 | 13.688 | 26.364 | 28.883 | 46.559 | 61.713 | 48.482 | 61.812 | 65.521 | 49.153 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 390 | 147 | 1.227 | 5.835 | 0 | 2.753 | 8.366 | 10.117 | 3.887 | 11.104 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.719 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medicina Integrativa S.r.l.